Researchers recruited 50 insulin-naive patients with type 2 diabetes and found that those who received Novo Nordisk's investigational long-acting oral basal insulin I338, which is now discontinued, and sham injection, and those who received insulin glargine injection and placebo tablet showed no significant differences in fasting plasma glucose reductions at eight weeks and in adverse event rates. The findings were published in The Lancet Diabetes & Endocrinology.
A study in the Journal of Diabetes and its Complications showed that demonstrating the injection process, explaining insulin benefits, using an authoritarian or collaborative style and dispelling insulin myths are the factors that could help type 2 diabetes patients to use insulin. Based on an online survey of 594 adult diabetes patients with a mean age of 53.3, findings revealed that those who said the injection process demonstration was the most helpful approach were less likely to delay insulin treatment.
The number of US adults with diabetes increased from 21.2 million in 2003-2004 to 30.2 million in 2013-2014, while the prevalence of obesity rose from 31.7% to 37.5% over the same period, according to findings published in Obesity. Researchers evaluated data from the National Health and Nutrition Examination Survey involving 32,188 individuals, finding an increase in mean body mass index, abdominal obesity and overall percentages of participants who met thresholds for overweight or obesity, and researcher Dr. Peter Toth said the cost trends associated with the conditions will remain unsustainable.
A study in Diabetes Care showed that patients with diabetes who took viscous fiber supplements had better blood glucose control and lower A1C and fasting blood glucose levels than those who didn't take viscous fiber. Canadian researchers analyzed data from 28 clinical trials involving 1,394 patients and found that taking viscous fiber supplements also led to improved insulin sensitivity.
UK researchers found several common gene variants tied to obesity, and new and other genetic regions that were associated with severe obesity and "healthy thinness." The findings in the journal PLOS Genetics, based on an analysis of the DNA of more than 13,600 individuals, revealed a higher genetic risk score among people with obesity than those with normal weight, as well as fewer genetic variants tied to an increased risk of being overweight among thin people.
A report from the Institute for Medicaid Innovation called for greater use of the clinical billing codes Z56 and Z59, which deal with social determinants of health, to help Medicaid managed care patients get needed help. The report said many Medicaid managed care plans and state and local agencies are doing more to address SDOH and the Z codes allow ICD-10 to log information about a patient's living and social environment.
A report released by the Government Accountability Office shows that more standardized methods of including demographic data in EHRs may bolster the accuracy of matching patient records, leading to improved delivery of health services. GAO also notes that inaccurate patient matching would negatively affect patient care and privacy.
A group of 38 US hospitals sued HHS over its site-neutral policy that could reduce Medicare payments for hospital outpatient visits. A similar lawsuit was filed in December by the American Hospital Association, the Association of American Medical Colleges and three hospitals.
The partial government shutdown, the longest in US history, is raising concerns about some health care services, the health insurance market and the Affordable Care Act. Congressional Democrats said ongoing staff shortages at the IRS could result in higher costs for some who need tax credits to reduce their insurance premiums, insurers said delays in rule-making have left them scrambling to make decisions about the ACA's individual market, and the Indian Health Service has been unable to pay tribal clinics and programs.